Hydrochloric Acid → 1-[(5-Methoxychroman-3-YL)methyl]-4-benzylpiperazine
Reaktionsgleichung
FC1C=CC2OC(C(N3CCN(CC4C=CC=CC=4)CC3)=O)CC=2C=1.Cl.[CH3:27][O:28][C:29]1[CH:38]=[CH:37][CH:36]=[C:35]2[C:30]=1[CH2:31][CH:32]([C:39]([N:41]1[CH2:46][CH2:45][N:44]([CH2:47][C:48]3[CH:53]=[CH:52][CH:51]=[CH:50][CH:49]=3)[CH2:43][CH2:42]1)=O)[CH2:33][O:34]2>>[CH3:27][O:28][C:29]1[CH:38]=[CH:37][CH:36]=[C:35]2[C:30]=1[CH2:31][CH:32]([CH2:39][N:41]1[CH2:42][CH2:43][N:44]([CH2:47][C:48]3[CH:53]=[CH:52][CH:51]=[CH:50][CH:49]=3)[CH2:45][CH2:46]1)[CH2:33][O:34]2Komponenten
4
Versuchsvorschrift
By carrying out the preparation as in Example 1, but replacing 1-[(5-fluoro-2,3-dihydrobenzofur-2-yl) carbonyl]-4-benzylpiperazine with the hydrochloride of 1-[(5-methoxychroman-3-yl) carbonyl]-4-benzylpiperazine obtained in Stage A, the title product is obtained.